Legacy Wealth Asset Management LLC decreased its stake in Haleon plc (NYSE:HLN – Free Report) by 5.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 68,238 shares of the company’s stock after selling 4,022 shares during the quarter. Legacy Wealth Asset Management LLC’s holdings in Haleon were worth $651,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in HLN. Rhumbline Advisers raised its position in shares of Haleon by 20.0% in the 2nd quarter. Rhumbline Advisers now owns 48,966 shares of the company’s stock valued at $404,000 after acquiring an additional 8,160 shares during the period. Brown Brothers Harriman & Co. increased its stake in Haleon by 21.4% in the second quarter. Brown Brothers Harriman & Co. now owns 7,569 shares of the company’s stock valued at $63,000 after purchasing an additional 1,334 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Haleon by 2.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,007,458 shares of the company’s stock worth $8,322,000 after purchasing an additional 24,673 shares during the period. Axxcess Wealth Management LLC boosted its position in shares of Haleon by 39.2% during the second quarter. Axxcess Wealth Management LLC now owns 62,393 shares of the company’s stock worth $515,000 after purchasing an additional 17,569 shares in the last quarter. Finally, Mercer Global Advisors Inc. ADV grew its holdings in shares of Haleon by 7.5% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 150,817 shares of the company’s stock valued at $1,246,000 after buying an additional 10,577 shares during the period. Institutional investors own 6.67% of the company’s stock.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. UBS Group upgraded Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Morgan Stanley downgraded shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $10.95.
Haleon Price Performance
NYSE:HLN opened at $9.24 on Friday. The stock’s 50-day simple moving average is $9.54 and its 200 day simple moving average is $9.69. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a market cap of $41.80 billion, a P/E ratio of 27.16, a P/E/G ratio of 2.52 and a beta of 0.29.
Haleon Profile
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Recommended Stories
- Five stocks we like better than Haleon
- Business Services Stocks Investing
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Stock Average Calculator
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.